BCR-ABL mRNA levels at and after the time of a complete cytogenetic response (CCR) predict the duration of CCR in imatinib mesylate–treated patients with CML

Richard D. Press, Brian Druker, Ashlie Tronnes et al.|Blood|2006

Cited by 126